Showing results (1581-1590 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|March 8, 2005
The diffusion of health economics knowledge in Europe : The EURONHEED (European Network of Health Economics Evaluation Database) projectGérard de Pouvourville, Philippe Ulmann, John Nixon, et al.Pharmacoeconomics|March 8, 2005
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorderJosé-Luis Fernandez, Stuart Montgomery, Clément FrancoisPharmacoeconomics|March 8, 2005
Providing systematic guidance in pharmacoeconomic guidelines for analysing costsPhilip Jacobs, Arto Ohinmaa, Bruce BradyPharmacoeconomics|June 30, 2023
Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)Nick Jovanoski, Seye Abogunrin, Danilo Di Maio, et al.Pharmacoeconomics|June 25, 2023
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in AustraliaPreston Ngo, Deme Karikios, David Goldsbury, et al.Pharmacoeconomics|June 16, 2023
Health Economic Research Assessing the Value of Early Detection of Cardiovascular Disease: A Systematic ReviewMartijn J Oude Wolcherink, Carina M Behr, Xavier G L V Pouwels, et al.Pharmacoeconomics|June 9, 2023
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key DriversAurelie Meunier, Louise Longworth, Manuel Gomes, et al.Pharmacoeconomics|June 10, 2023
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP RegistryXinyu Li, Rudolf Hoogenveen, Mohamed El Alili, et al.Pharmacoeconomics|November 24, 2018
Economic Burden of Renal Cell Carcinoma-Part I: An Updated ReviewChun-Ru Chien, Daniel M Geynisman, Bumyang Kim, et al.Pharmacoeconomics|May 12, 2018
A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility ValuesStavros Petrou, Joseph Kwon, Jason MadanPageof 336